Increased Pericyte Coverage Mediated by Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle–Like Cells in Pulmonary Hypertension
Abstract
Background—: Pericytes and their crosstalk with endothelial cells are critical for the development of a functional microvasculature and vascular remodeling. It is also known that pulmonary endothelial dysfunction is intertwined with the initiation and progression of pulmonary arterial hypertension (PAH). We hypothesized that pulmonary endothelial dysfunction, characterized by abnormal fibroblast growth factor-2 and interleukin-6 signaling, leads to abnormal microvascular pericyte coverage causing pulmonary arterial medial thickening. Methods and Results—: In human lung tissues, numbers of pericytes are substantially increased (up to 2-fold) in distal PAH pulmonary arteries compared with controls. Interestingly, human pulmonary pericytes exhibit, in vitro, an accentuated proliferative and migratory response to conditioned media from human idiopathic PAH endothelial cells compared with conditioned media from control cells. Importantly, by using an anti–fibroblast growth factor-2 neutralizing antibody, we attenuated these proliferative and migratory responses, whereas by using an anti–interleukin-6 neutralizing antibody, we decreased the migratory response without affecting the proliferative response. Furthermore, in our murine retinal angiogenesis model, both fibroblast growth factor-2 and interleukin-6 administration increased pericyte coverage. Finally, using idiopathic PAH human and NG2DsRedBAC mouse lung tissues, we demonstrated that this increased pericyte coverage contributes to pulmonary vascular remodeling as a source of smooth muscle–like cells. Furthermore, we found that transforming growth factor-β, in contrast to fibroblast growth factor-2 and interleukin-6, promotes human pulmonary pericyte differentiation into contractile smooth muscle–like cells. Conclusions—: To the best of our knowledge, this is the first report of excessive pericyte coverage in distal pulmonary arteries in human PAH. We also show that this phenomenon is directly linked with pulmonary endothelial dysfunction.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Proper expression of IL-6 by pericytes is important for the integrity of the BBB.
“The proper expression of IL-6 by pericytes was suggested to be important for the integrity of BBB.507,508”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [507]
Cites
Endothelial/Pericyte Interactions
Armulik, A., Abramsson, A., & Betsholtz, C. (2005) · Circulation Research · doi:10.1161/01.res.0000182903.16652.d7 · Cited by 2,048 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668 · see citing works
“The proper expression of IL-6 by pericytes was suggested to be important for the integrity of BBB.507,508 In an in vitro experiment, Scotter et al. found that dysfunction of TDP-43 in pericytes suppressed the expression of IL-6 by pericytes,509 indicating that TDP-43 loss-of-function may contribute to the pathology of…”
BackgroundInfluentialInflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R. (2014) · Circulation Research · doi:10.1161/circresaha.113.301141 · Cited by 1,029 · see citing works
Self-citationPericytes, Microvasular Dysfunction, and Chronic Rejection
Kloc, M., Kubiak, J. Z., Li, X. C., & Ghobrial, R. M. (2015) · Transplantation · doi:10.1097/tp.0000000000000648 · Cited by 34 · see citing works
- Authors
- Ricard, N., Tu, L., Le Hiress, M., Huertas, A., Phan, C., Thuillet, R., Sattler, C., Fadel, E., Seferian, A., Montani, D., Dorfmüller, P., Humbert, M., & Guignabert, C.
- Affiliations
- Inserm (FR)
- From the National Institute of Health and Medical Research, Unit 999, LabEx Laboratory of Excellence in Research on Medication and Innovative Therapeutics, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France (N.R., L.T., M.L.H., A.H., C.P., R.T., C.S., E.F., A.S., D.M., P.D., M.H., C.G.); University Paris-Sud, School of Medicine, Kremlin-Bicêtre, France (N.R., L.T., M.L.H., A.H., C.P., R.T., C.S., E.F., A.S., D.M., P.D., M.H., C.G.); and Public Hospitals of Paris, Pneumology Service,...
- ORCID
- Venue
- Circulation
- Published
- 2014-04-15
- Volume
- 129
- Issue
- 15
- Pages
- 1586-1597
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1975693842
- Cited by
- 208
- References
- 1
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 15 · 2023: 19 · 2022: 14 · 2021: 14 · 2020: 26 · 2019: 16 · 2018: 24 · 2017: 14 · 2016: 20 · 2015: 19 · 2014: 9 · 2013: 1
- FWCI
- 16.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- National Institute for Health and Care Research
- Agence Nationale de la Recherche (ANR-12-JSV1-0004)
- Institut National de la Santé et de la Recherche Médicale
- National Institutes of Health
- CHIST-ERA
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics › Vascular Anomalies and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- pulmonary arterial hypertension, pericytes, pericyte coverage, endothelial dysfunction, fibroblast growth factor 2, interleukin-6, smooth muscle-like cells, pulmonary vascular remodeling, TGF-beta
- MeSH terms
- Adult, Animals, Cell Communication, Cell Differentiation, Cells, Cultured, Disease Models, Animal, Female, Humans, Hypertension, Pulmonary, Male, Mice, Transgenic, Microcirculation, Middle Aged, Muscle, Smooth, Vascular, Pulmonary Circulation, Retinal Vessels, Interleukin-6, Fibroblast Growth Factor 2, Rats, Wistar, Neovascularization, Physiologic, Pericytes, Endothelial Cells, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review